Literature DB >> 31663672

Long-read nanopore sequencing resolves a TMEM231 gene conversion event causing Meckel-Gruber syndrome.

Christopher M Watson1,2, Philip Dean1, Nick Camm1, Jennifer Bates1, Ian M Carr2, Carol A Gardiner3, David T Bonthron1,2.   

Abstract

The diagnostic deployment of massively parallel short-read next-generation sequencing (NGS) has greatly improved genetic test availability, speed, and diagnostic yield, particularly for rare inherited disorders. Nonetheless, diagnostic approaches based on short-read sequencing have a poor ability to accurately detect gene conversion events. We report on the genetic analysis of a family in which 3 fetuses had clinical features consistent with the autosomal recessive disorder Meckel-Gruber syndrome (MKS). Targeted NGS of 29 known MKS-associated genes revealed a heterozygous TMEM231 splice donor variant c.929+1A>G. Comparative read-depth analysis, performed to identify a second pathogenic allele, revealed an apparent heterozygous deletion of TMEM231 exon 4. To verify this result we performed single-molecule long-read sequencing of a long-range polymerase chain reaction product spanning this locus. We identified four missense variants that were absent from the short-read dataset due to the preferential mapping of variant-containing reads to a downstream TMEM231 pseudogene. Consistent with the parental segregation analysis, we demonstrate that the single-molecule long reads could be used to show that the variants are arranged in trans. Our experience shows that robust validation of apparent dosage variants remains essential to avoid the pitfalls of short-read sequencing and that new third-generation long-read sequencing technologies can already aid routine clinical care.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Meckel-Gruber syndrome; TMEM231; gene conversion; nanopore sequencing

Mesh:

Substances:

Year:  2019        PMID: 31663672     DOI: 10.1002/humu.23940

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

Review 1.  Molecular Diagnostics of Ciliopathies and Insights Into Novel Developments in Diagnosing Rare Diseases.

Authors:  K Modarage; S A Malik; P Goggolidou
Journal:  Br J Biomed Sci       Date:  2022-01-10       Impact factor: 2.432

2.  Molecular characterization of pathogenic OTOA gene conversions in hearing loss patients.

Authors:  Sacha Laurent; Corinne Gehrig; Thierry Nouspikel; Sami S Amr; Andrea Oza; Elissa Murphy; Anne Vannier; Frédérique Sloan Béna; Maria Teresa Carminho-Rodrigues; Jean-Louis Blouin; Hélène Cao Van; Marc Abramowicz; Ariane Paoloni-Giacobino; Michel Guipponi
Journal:  Hum Mutat       Date:  2021-03-14       Impact factor: 4.878

3.  Consistent ultra-long DNA sequencing with automated slow pipetting.

Authors:  Trent M Prall; Emma K Neumann; Julie A Karl; Cecilia G Shortreed; David A Baker; Hailey E Bussan; Roger W Wiseman; David H O'Connor
Journal:  BMC Genomics       Date:  2021-03-12       Impact factor: 3.969

4.  A Novel Homozygous Variant of TMEM231 in a Case With Hypoplasia of the Cerebellar Vermis and Polydactyly.

Authors:  Tao Wang; Yu-Xing Liu; Fang-Mei Luo; Yi Dong; Ya-Li Li; Liang-Liang Fan
Journal:  Front Pediatr       Date:  2021-11-29       Impact factor: 3.418

5.  Long-read nanopore DNA sequencing can resolve complex intragenic duplication/deletion variants, providing information to enable preimplantation genetic diagnosis.

Authors:  Christopher M Watson; Deborah L Holliday; Laura A Crinnion; David T Bonthron
Journal:  Prenat Diagn       Date:  2022-01-18       Impact factor: 3.242

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.